Form D · Other Health Care
DENTULU INC
Los Angeles, CA · CIK 0001854187
Offering snapshot reported Apr 29, 2022 · SEC filing
- Reported sold
- $3.29M Offering amount: $4.32M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Apr 19, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 29, 2022 | Initial | $3,292,004 | No comparison | 26 | SEC filing |
| Feb 15, 2022 | Amendment | $3,092,000 | $545,000vs Mar 31, 2021 | 25 | SEC filing |
| Mar 31, 2021 | Initial | $2,547,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-443958
$3,092,000.00 of the Total Amount Sold referenced above was in connection with the conversion of SAFEs into Series Seed-2 Preferred Stock.
Series Seed-1 and Series Seed-2 Preferred Stock and Common Stock issuable upon conversion thereof.
Source: Form D, filed Apr 29, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shivakumar Chandrasekaran | Director, Executive |
| Maribel Gonzalez | Director, Executive |
| Arash Hakhamian | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2002 South Hoover Street
Los Angeles, CA, 90007
Los Angeles, CA, 90007